299 related articles for article (PubMed ID: 30728070)
21. Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro.
Oh BR; Suh DH; Bae D; Ha N; Choi YI; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Arthritis Res Ther; 2017 Jul; 19(1):154. PubMed ID: 28673326
[TBL] [Abstract][Full Text] [Related]
22. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
Porter NJ; Mahendran A; Breslow R; Christianson DW
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
[TBL] [Abstract][Full Text] [Related]
23. Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models.
Huang P; Almeciga-Pinto I; Jarpe M; van Duzer JH; Mazitschek R; Yang M; Jones SS; Quayle SN
Oncotarget; 2017 Jan; 8(2):2694-2707. PubMed ID: 27926524
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors.
Bae J; Hideshima T; Tai YT; Song Y; Richardson P; Raje N; Munshi NC; Anderson KC
Leukemia; 2018 Sep; 32(9):1932-1947. PubMed ID: 29487385
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells.
de Zoeten EF; Wang L; Butler K; Beier UH; Akimova T; Sai H; Bradner JE; Mazitschek R; Kozikowski AP; Matthias P; Hancock WW
Mol Cell Biol; 2011 May; 31(10):2066-78. PubMed ID: 21444725
[TBL] [Abstract][Full Text] [Related]
26. Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.
Ren J; Liao X; Vieson MD; Chen M; Scott R; Kazmierczak J; Luo XM; Reilly CM
Clin Exp Immunol; 2018 Jan; 191(1):19-31. PubMed ID: 28876451
[TBL] [Abstract][Full Text] [Related]
27. Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice.
Zhang L; Liu C; Wu J; Tao JJ; Sui XL; Yao ZG; Xu YF; Huang L; Zhu H; Sheng SL; Qin C
J Alzheimers Dis; 2014; 41(4):1193-205. PubMed ID: 24844691
[TBL] [Abstract][Full Text] [Related]
28. An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease.
Yanda MK; Liu Q; Cebotaru L
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F997-F1004. PubMed ID: 28747357
[TBL] [Abstract][Full Text] [Related]
29. A potent hydroxamic acid-based, small-molecule inhibitor A452 preferentially inhibits HDAC6 activity and induces cytotoxicity toward cancer cells irrespective of p53 status.
Ryu HW; Shin DH; Lee DH; Won HR; Kwon SH
Carcinogenesis; 2018 Jan; 39(1):72-83. PubMed ID: 29106445
[TBL] [Abstract][Full Text] [Related]
30. Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine.
Cosenza M; Civallero M; Marcheselli L; Sacchi S; Pozzi S
Apoptosis; 2017 Jun; 22(6):827-840. PubMed ID: 28315173
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes.
Wang JH; Shih KS; Wu YW; Wang AW; Yang CR
Osteoarthritis Cartilage; 2013 Dec; 21(12):1987-96. PubMed ID: 24107356
[TBL] [Abstract][Full Text] [Related]
32. Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma.
Vogl DT; Raje N; Jagannath S; Richardson P; Hari P; Orlowski R; Supko JG; Tamang D; Yang M; Jones SS; Wheeler C; Markelewicz RJ; Lonial S
Clin Cancer Res; 2017 Jul; 23(13):3307-3315. PubMed ID: 28053023
[No Abstract] [Full Text] [Related]
33. HDAC expression and activity is upregulated in diseased lupus-prone mice.
Regna NL; Vieson MD; Gojmerac AM; Luo XM; Caudell DL; Reilly CM
Int Immunopharmacol; 2015 Dec; 29(2):494-503. PubMed ID: 26471208
[TBL] [Abstract][Full Text] [Related]
34. Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice.
Regna NL; Vieson MD; Luo XM; Chafin CB; Puthiyaveetil AG; Hammond SE; Caudell DL; Jarpe MB; Reilly CM
Clin Immunol; 2016 Jan; 162():58-73. PubMed ID: 26604012
[TBL] [Abstract][Full Text] [Related]
35. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.
Vishwakarma S; Iyer LR; Muley M; Singh PK; Shastry A; Saxena A; Kulathingal J; Vijaykanth G; Raghul J; Rajesh N; Rathinasamy S; Kachhadia V; Kilambi N; Rajgopal S; Balasubramanian G; Narayanan S
Int Immunopharmacol; 2013 May; 16(1):72-8. PubMed ID: 23541634
[TBL] [Abstract][Full Text] [Related]
36. The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease.
Cosenza M; Pozzi S
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096875
[TBL] [Abstract][Full Text] [Related]
37. HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy.
Krukowski K; Ma J; Golonzhka O; Laumet GO; Gutti T; van Duzer JH; Mazitschek R; Jarpe MB; Heijnen CJ; Kavelaars A
Pain; 2017 Jun; 158(6):1126-1137. PubMed ID: 28267067
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma.
Peng X; Li L; Chen J; Ren Y; Liu J; Yu Z; Cao H; Chen J
J Med Chem; 2022 Feb; 65(3):2434-2457. PubMed ID: 35043615
[TBL] [Abstract][Full Text] [Related]
39. CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus.
Choi EW; Song JW; Ha N; Choi YI; Kim S
Sci Rep; 2018 Nov; 8(1):17297. PubMed ID: 30470828
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity.
Cabrero JR; Serrador JM; Barreiro O; Mittelbrunn M; Naranjo-Suárez S; Martín-Cófreces N; Vicente-Manzanares M; Mazitschek R; Bradner JE; Avila J; Valenzuela-Fernández A; Sánchez-Madrid F
Mol Biol Cell; 2006 Aug; 17(8):3435-45. PubMed ID: 16738306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
